ADC Therapeutics SA

Forecast & Rating5 analysts currently cover ADC Therapeutics SA, with about 60.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $5.00, about 334.8% upside from the current price of $1.15. Price targets range from $2.00 to $10.00 — a wide spread, showing clear disagreement over just how much ADC Therapeutics SA can rise. Historically, about 3.0% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study ADC Therapeutics SA closely still see room for the stock to rise. Data as of Jul 21, 2026; for reference only and not investment advice.